VitaNova Life Sciences EBITDA Growth & History (VNOV)

VitaNova Life Sciences's calculated EBITDA was $6,581 for fiscal 2026.

View full VitaNova Life Sciences company overview

VitaNova Life Sciences annual ebitda history

VitaNova Life Sciences annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20262026-04-30$6,581−$1.2M−99.46%
20252025-04-30$1.2M$1.0M+487.56%
20242024-04-30$205,734$229,961
20232023-04-30−$24,227
20192019-04-30−$71,811−$23,162
20182018-04-30−$48,649

VitaNova Life Sciences ebitda trends

Between the periods ended 2018-04-30 and 2026-04-30, VitaNova Life Sciences's ebitda increased from −$48,649 to $6,581, a change of $55,230. The latest reported quarter, Q4 2026, shows −$107,000.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review VitaNova Life Sciences source filings ↗

Community posts

It’s quiet here.

No posts about VNOV yet. Start the conversation.

Write the first post